| ALT | alternative lengthening of telomeres. |
| BMAC | bone marrow aspirate concentrate. |
| BPC-157 | Body Protection Compound-157. |
| EMT | epithelial–mesenchymal transition. |
| FDA | U.S. Food and Drug Administration. |
| hTERT | human telomerase reverse transcriptase. |
| IND | Investigational New Drug. |
| MMP | matrix metalloproteinase. |
| OA | osteoarthritis. |
| PCAC | Pharmacy Compounding Advisory Committee. |
| PK | pharmacokinetic. |
| PRP | platelet-rich plasma. |
| RCT | randomized controlled trial. |
| ROS | reactive oxygen species. |
| RPE | retinal pigment epithelium. |
| SASP | senescence-associated secretory phenotype. |
| SOD | superoxide dismutase. |
| SPPS | solid-phase peptide synthesis. |